16:54 Fri 30 Jul 2021
Diaceutics PLC - PDMR Shareholding/Share Incentive Plan
Diaceutics PLC
("Diaceutics" or "the Company")
PDMR Shareholding/Share Incentive Plan
Diaceutics PLC, (AIM: DXRX), the diagnostic commercialisation company for precision testing has been notified that on
It was announced on
A one-off option or conditional award in respect of purchases by each PDMR up to and including
Name |
Number of Share Options granted |
Type of Matched Award |
Normal Vesting Date |
Susanne Munksted (MD and PDMR) |
Such number of Shares as is equal to two times the number of Shares purchased up to and including |
Conditional share award |
|
|
Nil cost option |
|
Enquiries:
Diaceutics PLC |
|
|
Via Alma PR |
|
|
Stifel Nicolaus Europe Limited (Nomad & Broker) |
Tel: +44 (0)20 7710 7600 |
|
|
|
|
|
|
|
|
Alma PR |
Tel: +44(0)20 3405 0205 |
|
|
|
|
|
|
About Diaceutics
At Diaceutics we believe that every patient should have access to the right treatment at the right time. We provide the world's leading pharmaceutical companies with an end-to-end solution for the launch of precision medicine diagnostics enabled by DXRX - The Diagnostic Network®.
DXRX is the world's first diagnostic commercialisation platform for precision medicine, integrating multiple pipelines of real-world diagnostic testing data from a global network of laboratories.
Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014 |
|||||||
1 |
Details of the person discharging managerial responsibilities/person closely associated |
||||||
a. |
Name |
Susanne Munksted |
|||||
2 |
Reason for notification |
|
|||||
a. |
Position/Status |
Managing Director and PDMR |
|||||
b. |
Initial notification/ Amendment |
Initial |
|||||
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||||
a. |
Name |
Diaceutics PLC |
|||||
b. |
LEI |
213800VEWQBB39ZB8J81 |
|||||
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||||
a. |
Description of the financial instrument, type of instrument |
Ordinary shares of £0.002 each
ISIN: GB00BJQTGV64 |
|||||
b. |
Nature of the transaction |
Ongoing non-discretionary purchase of Shares matched by the grant of conditional share award over Shares under the Global Share Incentive Plan ("SIP") |
|||||
c. |
Price(s) and volume(s) |
|
Share purchase: |
|
|
|
|
|
Price(s) |
Volume(s) |
|
||||
112.00 p |
127 |
|
|||||
|
Conditional share award: |
|
|||||
|
Price(s) |
Volume(s) |
|
||||
|
Nil |
Two times the number of Shares purchased up to and including |
|
||||
|
|||||||
e. |
Date of the transaction |
Share purchase: Conditional share award Option award: |
|||||
f. |
Place of the transaction |
Share Purchase: AIM Market of the London Stock Exchange Conditional share award: Off-Market |
|||||
Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014 |
|||||||
1 |
Details of the person discharging managerial responsibilities/person closely associated |
||||||
a. |
Name |
|
|||||
2 |
Reason for notification |
|
|||||
a. |
Position/Status |
Chief Operating Officer and PDMR |
|||||
b. |
Initial notification/ Amendment |
Initial |
|||||
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||||
a. |
Name |
Diaceutics PLC |
|||||
b. |
LEI |
213800VEWQBB39ZB8J81 |
|||||
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||||
a. |
Description of the financial instrument, type of instrument |
Ordinary shares of £0.002 each
ISIN: GB00BJQTGV64 |
|||||
b. |
Nature of the transaction |
Ongoing non-discretionary purchase of Shares to matched by the grant of nil cost options over Shares under the Global Share Incentive Plan ("SIP") |
|||||
c. |
Price(s) and volume(s) |
|
Share purchase: |
|
|
|
|
|
Price(s) |
Volume(s) |
|
||||
112.00 p |
132 |
|
|||||
|
Options: |
|
|||||
|
Price(s) |
Volume(s) |
|
||||
|
Nil |
Two times the number of Shares purchased up to and including |
|
||||
|
|||||||
e. |
Date of the transaction |
Share purchase: Option award: |
|||||
f. |
Place of the transaction |
Share Purchase: AIM Market of the London Stock Exchange Option award: Off-Market |
|||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...
FOR OUR FULL DISCLAIMER CLICK HERE